nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—chronic kidney failure—Calcium Acetate—osteoporosis	0.221	0.416	CpDpCtD
Bumetanide—chronic kidney failure—Calcitriol—osteoporosis	0.168	0.315	CpDpCtD
Bumetanide—chronic kidney failure—Cholecalciferol—osteoporosis	0.143	0.268	CpDpCtD
Bumetanide—CA14—Zoledronate—osteoporosis	0.0706	0.194	CbGbCtD
Bumetanide—SLC10A1—Ethinyl Estradiol—osteoporosis	0.0639	0.176	CbGbCtD
Bumetanide—CA12—Zoledronate—osteoporosis	0.0501	0.138	CbGbCtD
Bumetanide—SLC10A1—Conjugated Estrogens—osteoporosis	0.0469	0.129	CbGbCtD
Bumetanide—PTGS2—Risedronate—osteoporosis	0.0327	0.09	CbGbCtD
Bumetanide—SLC22A11—Conjugated Estrogens—osteoporosis	0.0214	0.0589	CbGbCtD
Bumetanide—SLC22A11—Estradiol—osteoporosis	0.0188	0.0517	CbGbCtD
Bumetanide—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0143	0.0394	CbGbCtD
Bumetanide—SLCO1A2—Estradiol—osteoporosis	0.0126	0.0346	CbGbCtD
Bumetanide—SLC22A8—Conjugated Estrogens—osteoporosis	0.0125	0.0343	CbGbCtD
Bumetanide—SLC22A8—Estradiol—osteoporosis	0.0109	0.0301	CbGbCtD
Bumetanide—SLC22A6—Conjugated Estrogens—osteoporosis	0.00867	0.0239	CbGbCtD
Bumetanide—Furosemide—CA2—osteoporosis	0.00101	0.537	CrCbGaD
Bumetanide—Indapamide—CA2—osteoporosis	0.00087	0.463	CrCbGaD
Bumetanide—Pancreatitis—Calcitriol—osteoporosis	0.000351	0.00548	CcSEcCtD
Bumetanide—Abdominal discomfort—Ibandronate—osteoporosis	0.000351	0.00548	CcSEcCtD
Bumetanide—Hyperglycaemia—Estropipate—osteoporosis	0.000344	0.00538	CcSEcCtD
Bumetanide—Hearing impaired—Estradiol—osteoporosis	0.000338	0.00528	CcSEcCtD
Bumetanide—Erythema multiforme—Etidronic acid—osteoporosis	0.000334	0.00521	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.000332	0.00519	CcSEcCtD
Bumetanide—Musculoskeletal pain—Estradiol—osteoporosis	0.000326	0.00508	CcSEcCtD
Bumetanide—Renal failure—Ibandronate—osteoporosis	0.000321	0.00501	CcSEcCtD
Bumetanide—Sweating—Raloxifene—osteoporosis	0.000316	0.00493	CcSEcCtD
Bumetanide—Sweating—Ibandronate—osteoporosis	0.000313	0.00488	CcSEcCtD
Bumetanide—Blood creatinine increased—Pamidronate—osteoporosis	0.000311	0.00485	CcSEcCtD
Bumetanide—Hypokalaemia—Pamidronate—osteoporosis	0.000302	0.00471	CcSEcCtD
Bumetanide—Cramp muscle—Pamidronate—osteoporosis	0.000299	0.00466	CcSEcCtD
Bumetanide—Muscle spasms—Etidronic acid—osteoporosis	0.000296	0.00461	CcSEcCtD
Bumetanide—Abdominal discomfort—Risedronate—osteoporosis	0.000289	0.00451	CcSEcCtD
Bumetanide—Erythema multiforme—Estropipate—osteoporosis	0.000289	0.00451	CcSEcCtD
Bumetanide—Gynaecomastia—Estradiol—osteoporosis	0.000288	0.00449	CcSEcCtD
Bumetanide—Erythema multiforme—Alendronate—osteoporosis	0.000285	0.00444	CcSEcCtD
Bumetanide—Blood creatinine increased—Zoledronate—osteoporosis	0.000284	0.00443	CcSEcCtD
Bumetanide—Dehydration—Zoledronate—osteoporosis	0.000282	0.0044	CcSEcCtD
Bumetanide—Hypokalaemia—Zoledronate—osteoporosis	0.000276	0.00431	CcSEcCtD
Bumetanide—Leukopenia—Etidronic acid—osteoporosis	0.000275	0.0043	CcSEcCtD
Bumetanide—Asthenia—Calcium Acetate—osteoporosis	0.000274	0.00428	CcSEcCtD
Bumetanide—Blood creatinine increased—Conjugated Estrogens—osteoporosis	0.000273	0.00427	CcSEcCtD
Bumetanide—Cramp muscle—Zoledronate—osteoporosis	0.000273	0.00426	CcSEcCtD
Bumetanide—Dehydration—Conjugated Estrogens—osteoporosis	0.000271	0.00424	CcSEcCtD
Bumetanide—Erythema multiforme—Calcitriol—osteoporosis	0.000271	0.00423	CcSEcCtD
Bumetanide—Pruritus—Calcium Acetate—osteoporosis	0.00027	0.00422	CcSEcCtD
Bumetanide—Polyuria—Estradiol—osteoporosis	0.000266	0.00415	CcSEcCtD
Bumetanide—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.000266	0.00415	CcSEcCtD
Bumetanide—Cramp muscle—Conjugated Estrogens—osteoporosis	0.000263	0.0041	CcSEcCtD
Bumetanide—Arthralgia—Etidronic acid—osteoporosis	0.000262	0.00409	CcSEcCtD
Bumetanide—Diarrhoea—Calcium Acetate—osteoporosis	0.000262	0.00408	CcSEcCtD
Bumetanide—Muscle spasms—Estropipate—osteoporosis	0.000256	0.00399	CcSEcCtD
Bumetanide—Dizziness—Calcium Acetate—osteoporosis	0.000253	0.00395	CcSEcCtD
Bumetanide—Muscle spasms—Alendronate—osteoporosis	0.000252	0.00393	CcSEcCtD
Bumetanide—Renal failure—Pamidronate—osteoporosis	0.000251	0.00392	CcSEcCtD
Bumetanide—Abdominal discomfort—Zoledronate—osteoporosis	0.000251	0.00392	CcSEcCtD
Bumetanide—Muscle spasms—Raloxifene—osteoporosis	0.000248	0.00387	CcSEcCtD
Bumetanide—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000247	0.00386	CcSEcCtD
Bumetanide—Muscle spasms—Ibandronate—osteoporosis	0.000245	0.00383	CcSEcCtD
Bumetanide—Vomiting—Calcium Acetate—osteoporosis	0.000243	0.00379	CcSEcCtD
Bumetanide—Asthenia—Ergocalciferol—osteoporosis	0.000242	0.00378	CcSEcCtD
Bumetanide—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.000242	0.00377	CcSEcCtD
Bumetanide—Vertigo—Estropipate—osteoporosis	0.000239	0.00373	CcSEcCtD
Bumetanide—Vertigo—Alendronate—osteoporosis	0.000235	0.00367	CcSEcCtD
Bumetanide—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000234	0.00366	CcSEcCtD
Bumetanide—Vertigo—Raloxifene—osteoporosis	0.000232	0.00361	CcSEcCtD
Bumetanide—Renal failure—Zoledronate—osteoporosis	0.00023	0.00358	CcSEcCtD
Bumetanide—Vertigo—Ibandronate—osteoporosis	0.000229	0.00358	CcSEcCtD
Bumetanide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000228	0.00355	CcSEcCtD
Bumetanide—Nausea—Calcium Acetate—osteoporosis	0.000227	0.00354	CcSEcCtD
Bumetanide—Arthralgia—Estropipate—osteoporosis	0.000226	0.00354	CcSEcCtD
Bumetanide—Chest pain—Alendronate—osteoporosis	0.000223	0.00348	CcSEcCtD
Bumetanide—Renal failure—Conjugated Estrogens—osteoporosis	0.000221	0.00345	CcSEcCtD
Bumetanide—Chest pain—Raloxifene—osteoporosis	0.000219	0.00342	CcSEcCtD
Bumetanide—Arthralgia—Raloxifene—osteoporosis	0.000219	0.00342	CcSEcCtD
Bumetanide—Arthralgia—Ibandronate—osteoporosis	0.000217	0.00339	CcSEcCtD
Bumetanide—Chest pain—Ibandronate—osteoporosis	0.000217	0.00339	CcSEcCtD
Bumetanide—Chest pain—Calcitriol—osteoporosis	0.000213	0.00332	CcSEcCtD
Bumetanide—Dry mouth—Ibandronate—osteoporosis	0.000212	0.00332	CcSEcCtD
Bumetanide—Cramp muscle—Estradiol—osteoporosis	0.00021	0.00328	CcSEcCtD
Bumetanide—Dry mouth—Calcitriol—osteoporosis	0.000208	0.00325	CcSEcCtD
Bumetanide—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000207	0.00324	CcSEcCtD
Bumetanide—Thrombocytopenia—Raloxifene—osteoporosis	0.000206	0.00321	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000205	0.0032	CcSEcCtD
Bumetanide—Hyperhidrosis—Raloxifene—osteoporosis	0.000203	0.00317	CcSEcCtD
Bumetanide—Muscle spasms—Risedronate—osteoporosis	0.000202	0.00315	CcSEcCtD
Bumetanide—Hyperhidrosis—Ibandronate—osteoporosis	0.000201	0.00314	CcSEcCtD
Bumetanide—Nausea—Ergocalciferol—osteoporosis	0.000201	0.00313	CcSEcCtD
Bumetanide—Urticaria—Etidronic acid—osteoporosis	0.000199	0.00311	CcSEcCtD
Bumetanide—Abdominal pain—Etidronic acid—osteoporosis	0.000198	0.0031	CcSEcCtD
Bumetanide—Pancreatitis—Estradiol—osteoporosis	0.000198	0.00309	CcSEcCtD
Bumetanide—Abdominal discomfort—Estradiol—osteoporosis	0.000194	0.00302	CcSEcCtD
Bumetanide—Muscle spasms—Pamidronate—osteoporosis	0.000192	0.003	CcSEcCtD
Bumetanide—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000191	0.00298	CcSEcCtD
Bumetanide—Vertigo—Risedronate—osteoporosis	0.000189	0.00295	CcSEcCtD
Bumetanide—Fatigue—Estropipate—osteoporosis	0.000187	0.00292	CcSEcCtD
Bumetanide—Hyperglycaemia—Estradiol—osteoporosis	0.000182	0.00284	CcSEcCtD
Bumetanide—Fatigue—Ibandronate—osteoporosis	0.00018	0.0028	CcSEcCtD
Bumetanide—Arthralgia—Risedronate—osteoporosis	0.000179	0.00279	CcSEcCtD
Bumetanide—Chest pain—Risedronate—osteoporosis	0.000179	0.00279	CcSEcCtD
Bumetanide—Leukopenia—Pamidronate—osteoporosis	0.000179	0.00279	CcSEcCtD
Bumetanide—Pruritus—Etidronic acid—osteoporosis	0.000178	0.00277	CcSEcCtD
Bumetanide—Gastrointestinal pain—Estropipate—osteoporosis	0.000178	0.00277	CcSEcCtD
Bumetanide—Muscle spasms—Zoledronate—osteoporosis	0.000176	0.00274	CcSEcCtD
Bumetanide—Dry mouth—Risedronate—osteoporosis	0.000175	0.00273	CcSEcCtD
Bumetanide—Gastrointestinal pain—Alendronate—osteoporosis	0.000175	0.00273	CcSEcCtD
Bumetanide—Urticaria—Estropipate—osteoporosis	0.000172	0.00269	CcSEcCtD
Bumetanide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000172	0.00268	CcSEcCtD
Bumetanide—Diarrhoea—Etidronic acid—osteoporosis	0.000172	0.00268	CcSEcCtD
Bumetanide—Abdominal pain—Estropipate—osteoporosis	0.000172	0.00268	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ibandronate—osteoporosis	0.00017	0.00266	CcSEcCtD
Bumetanide—Arthralgia—Pamidronate—osteoporosis	0.00017	0.00266	CcSEcCtD
Bumetanide—Urticaria—Alendronate—osteoporosis	0.00017	0.00265	CcSEcCtD
Bumetanide—Abdominal pain—Alendronate—osteoporosis	0.000169	0.00264	CcSEcCtD
Bumetanide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000169	0.00264	CcSEcCtD
Bumetanide—Gastrointestinal pain—Calcitriol—osteoporosis	0.000167	0.0026	CcSEcCtD
Bumetanide—Abdominal pain—Raloxifene—osteoporosis	0.000166	0.00259	CcSEcCtD
Bumetanide—Urticaria—Ibandronate—osteoporosis	0.000165	0.00258	CcSEcCtD
Bumetanide—Abdominal pain—Ibandronate—osteoporosis	0.000165	0.00257	CcSEcCtD
Bumetanide—Vertigo—Zoledronate—osteoporosis	0.000164	0.00256	CcSEcCtD
Bumetanide—Leukopenia—Zoledronate—osteoporosis	0.000163	0.00255	CcSEcCtD
Bumetanide—Urticaria—Calcitriol—osteoporosis	0.000162	0.00253	CcSEcCtD
Bumetanide—Abdominal pain—Calcitriol—osteoporosis	0.000161	0.00251	CcSEcCtD
Bumetanide—Thrombocytopenia—Pamidronate—osteoporosis	0.00016	0.00249	CcSEcCtD
Bumetanide—Vomiting—Etidronic acid—osteoporosis	0.00016	0.00249	CcSEcCtD
Bumetanide—Rash—Etidronic acid—osteoporosis	0.000158	0.00247	CcSEcCtD
Bumetanide—Dermatitis—Etidronic acid—osteoporosis	0.000158	0.00247	CcSEcCtD
Bumetanide—Vertigo—Conjugated Estrogens—osteoporosis	0.000158	0.00246	CcSEcCtD
Bumetanide—Hyperhidrosis—Pamidronate—osteoporosis	0.000158	0.00246	CcSEcCtD
Bumetanide—Headache—Etidronic acid—osteoporosis	0.000157	0.00245	CcSEcCtD
Bumetanide—Asthenia—Estropipate—osteoporosis	0.000156	0.00243	CcSEcCtD
Bumetanide—Chest pain—Zoledronate—osteoporosis	0.000155	0.00243	CcSEcCtD
Bumetanide—Arthralgia—Zoledronate—osteoporosis	0.000155	0.00243	CcSEcCtD
Bumetanide—Pruritus—Estropipate—osteoporosis	0.000154	0.0024	CcSEcCtD
Bumetanide—Asthenia—Alendronate—osteoporosis	0.000153	0.00239	CcSEcCtD
Bumetanide—Erythema multiforme—Estradiol—osteoporosis	0.000153	0.00238	CcSEcCtD
Bumetanide—Hypotension—Pamidronate—osteoporosis	0.000152	0.00238	CcSEcCtD
Bumetanide—Dry mouth—Zoledronate—osteoporosis	0.000152	0.00237	CcSEcCtD
Bumetanide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000152	0.00237	CcSEcCtD
Bumetanide—Pruritus—Alendronate—osteoporosis	0.000151	0.00236	CcSEcCtD
Bumetanide—Arthralgia—Conjugated Estrogens—osteoporosis	0.00015	0.00234	CcSEcCtD
Bumetanide—Chest pain—Conjugated Estrogens—osteoporosis	0.00015	0.00234	CcSEcCtD
Bumetanide—Asthenia—Ibandronate—osteoporosis	0.000149	0.00233	CcSEcCtD
Bumetanide—Nausea—Etidronic acid—osteoporosis	0.000149	0.00233	CcSEcCtD
Bumetanide—Diarrhoea—Estropipate—osteoporosis	0.000149	0.00232	CcSEcCtD
Bumetanide—Fatigue—Risedronate—osteoporosis	0.000148	0.00231	CcSEcCtD
Bumetanide—Pruritus—Ibandronate—osteoporosis	0.000147	0.0023	CcSEcCtD
Bumetanide—Diarrhoea—Alendronate—osteoporosis	0.000146	0.00228	CcSEcCtD
Bumetanide—Asthenia—Calcitriol—osteoporosis	0.000146	0.00228	CcSEcCtD
Bumetanide—Thrombocytopenia—Zoledronate—osteoporosis	0.000146	0.00228	CcSEcCtD
Bumetanide—Pruritus—Calcitriol—osteoporosis	0.000144	0.00225	CcSEcCtD
Bumetanide—Hyperhidrosis—Zoledronate—osteoporosis	0.000144	0.00225	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000144	0.00225	CcSEcCtD
Bumetanide—Diarrhoea—Raloxifene—osteoporosis	0.000144	0.00225	CcSEcCtD
Bumetanide—Dizziness—Estropipate—osteoporosis	0.000144	0.00224	CcSEcCtD
Bumetanide—Diarrhoea—Ibandronate—osteoporosis	0.000142	0.00222	CcSEcCtD
Bumetanide—Dizziness—Alendronate—osteoporosis	0.000141	0.00221	CcSEcCtD
Bumetanide—Fatigue—Pamidronate—osteoporosis	0.000141	0.00219	CcSEcCtD
Bumetanide—Gastrointestinal pain—Risedronate—osteoporosis	0.00014	0.00219	CcSEcCtD
Bumetanide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00014	0.00218	CcSEcCtD
Bumetanide—Diarrhoea—Calcitriol—osteoporosis	0.000139	0.00218	CcSEcCtD
Bumetanide—Hypotension—Zoledronate—osteoporosis	0.000139	0.00217	CcSEcCtD
Bumetanide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000139	0.00217	CcSEcCtD
Bumetanide—Dizziness—Raloxifene—osteoporosis	0.000139	0.00217	CcSEcCtD
Bumetanide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000139	0.00216	CcSEcCtD
Bumetanide—Vomiting—Estropipate—osteoporosis	0.000138	0.00215	CcSEcCtD
Bumetanide—Dizziness—Ibandronate—osteoporosis	0.000138	0.00215	CcSEcCtD
Bumetanide—Rash—Estropipate—osteoporosis	0.000137	0.00214	CcSEcCtD
Bumetanide—Dermatitis—Estropipate—osteoporosis	0.000137	0.00213	CcSEcCtD
Bumetanide—Urticaria—Risedronate—osteoporosis	0.000136	0.00213	CcSEcCtD
Bumetanide—Headache—Estropipate—osteoporosis	0.000136	0.00212	CcSEcCtD
Bumetanide—Vomiting—Alendronate—osteoporosis	0.000136	0.00212	CcSEcCtD
Bumetanide—Abdominal pain—Risedronate—osteoporosis	0.000136	0.00212	CcSEcCtD
Bumetanide—Muscle spasms—Estradiol—osteoporosis	0.000135	0.00211	CcSEcCtD
Bumetanide—Rash—Alendronate—osteoporosis	0.000135	0.0021	CcSEcCtD
Bumetanide—Dermatitis—Alendronate—osteoporosis	0.000135	0.0021	CcSEcCtD
Bumetanide—Hypotension—Conjugated Estrogens—osteoporosis	0.000134	0.00209	CcSEcCtD
Bumetanide—Headache—Alendronate—osteoporosis	0.000134	0.00209	CcSEcCtD
Bumetanide—Vomiting—Raloxifene—osteoporosis	0.000134	0.00209	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000133	0.00208	CcSEcCtD
Bumetanide—Rash—Raloxifene—osteoporosis	0.000133	0.00207	CcSEcCtD
Bumetanide—Dermatitis—Raloxifene—osteoporosis	0.000132	0.00207	CcSEcCtD
Bumetanide—Vomiting—Ibandronate—osteoporosis	0.000132	0.00207	CcSEcCtD
Bumetanide—Headache—Raloxifene—osteoporosis	0.000132	0.00206	CcSEcCtD
Bumetanide—Rash—Ibandronate—osteoporosis	0.000131	0.00205	CcSEcCtD
Bumetanide—Dermatitis—Ibandronate—osteoporosis	0.000131	0.00205	CcSEcCtD
Bumetanide—Headache—Ibandronate—osteoporosis	0.00013	0.00204	CcSEcCtD
Bumetanide—Vomiting—Calcitriol—osteoporosis	0.00013	0.00202	CcSEcCtD
Bumetanide—Nausea—Estropipate—osteoporosis	0.000129	0.00201	CcSEcCtD
Bumetanide—Abdominal pain—Pamidronate—osteoporosis	0.000129	0.00201	CcSEcCtD
Bumetanide—Rash—Calcitriol—osteoporosis	0.000129	0.00201	CcSEcCtD
Bumetanide—Fatigue—Zoledronate—osteoporosis	0.000128	0.002	CcSEcCtD
Bumetanide—Dermatitis—Calcitriol—osteoporosis	0.000128	0.002	CcSEcCtD
Bumetanide—Headache—Calcitriol—osteoporosis	0.000128	0.00199	CcSEcCtD
Bumetanide—Nausea—Alendronate—osteoporosis	0.000127	0.00198	CcSEcCtD
Bumetanide—Vertigo—Estradiol—osteoporosis	0.000126	0.00197	CcSEcCtD
Bumetanide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000126	0.00197	CcSEcCtD
Bumetanide—Nausea—Raloxifene—osteoporosis	0.000125	0.00195	CcSEcCtD
Bumetanide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000125	0.00194	CcSEcCtD
Bumetanide—Fatigue—Conjugated Estrogens—osteoporosis	0.000124	0.00193	CcSEcCtD
Bumetanide—Nausea—Ibandronate—osteoporosis	0.000124	0.00193	CcSEcCtD
Bumetanide—Asthenia—Risedronate—osteoporosis	0.000123	0.00192	CcSEcCtD
Bumetanide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000122	0.0019	CcSEcCtD
Bumetanide—Pruritus—Risedronate—osteoporosis	0.000121	0.00189	CcSEcCtD
Bumetanide—Nausea—Calcitriol—osteoporosis	0.000121	0.00189	CcSEcCtD
Bumetanide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00012	0.00188	CcSEcCtD
Bumetanide—Chest pain—Estradiol—osteoporosis	0.00012	0.00187	CcSEcCtD
Bumetanide—Arthralgia—Estradiol—osteoporosis	0.00012	0.00187	CcSEcCtD
Bumetanide—Urticaria—Zoledronate—osteoporosis	0.000118	0.00185	CcSEcCtD
Bumetanide—Abdominal pain—Zoledronate—osteoporosis	0.000118	0.00184	CcSEcCtD
Bumetanide—Diarrhoea—Risedronate—osteoporosis	0.000117	0.00183	CcSEcCtD
Bumetanide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000117	0.00183	CcSEcCtD
Bumetanide—Dry mouth—Estradiol—osteoporosis	0.000117	0.00183	CcSEcCtD
Bumetanide—Asthenia—Pamidronate—osteoporosis	0.000117	0.00183	CcSEcCtD
Bumetanide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000116	0.00182	CcSEcCtD
Bumetanide—Pruritus—Pamidronate—osteoporosis	0.000115	0.0018	CcSEcCtD
Bumetanide—Urticaria—Conjugated Estrogens—osteoporosis	0.000114	0.00178	CcSEcCtD
Bumetanide—Dizziness—Risedronate—osteoporosis	0.000113	0.00177	CcSEcCtD
Bumetanide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000113	0.00177	CcSEcCtD
Bumetanide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000112	0.00175	CcSEcCtD
Bumetanide—Diarrhoea—Pamidronate—osteoporosis	0.000112	0.00174	CcSEcCtD
Bumetanide—Hyperhidrosis—Estradiol—osteoporosis	0.000111	0.00173	CcSEcCtD
Bumetanide—Rash—Ethinyl Estradiol—osteoporosis	0.000111	0.00173	CcSEcCtD
Bumetanide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000111	0.00173	CcSEcCtD
Bumetanide—Headache—Ethinyl Estradiol—osteoporosis	0.00011	0.00172	CcSEcCtD
Bumetanide—Vomiting—Risedronate—osteoporosis	0.000109	0.0017	CcSEcCtD
Bumetanide—Rash—Risedronate—osteoporosis	0.000108	0.00169	CcSEcCtD
Bumetanide—Dermatitis—Risedronate—osteoporosis	0.000108	0.00169	CcSEcCtD
Bumetanide—Dizziness—Pamidronate—osteoporosis	0.000108	0.00168	CcSEcCtD
Bumetanide—Headache—Risedronate—osteoporosis	0.000107	0.00168	CcSEcCtD
Bumetanide—Asthenia—Zoledronate—osteoporosis	0.000107	0.00167	CcSEcCtD
Bumetanide—Pruritus—Zoledronate—osteoporosis	0.000105	0.00165	CcSEcCtD
Bumetanide—Nausea—Ethinyl Estradiol—osteoporosis	0.000105	0.00163	CcSEcCtD
Bumetanide—Vomiting—Pamidronate—osteoporosis	0.000104	0.00162	CcSEcCtD
Bumetanide—Asthenia—Conjugated Estrogens—osteoporosis	0.000103	0.00161	CcSEcCtD
Bumetanide—Rash—Pamidronate—osteoporosis	0.000103	0.00161	CcSEcCtD
Bumetanide—Dermatitis—Pamidronate—osteoporosis	0.000103	0.0016	CcSEcCtD
Bumetanide—Headache—Pamidronate—osteoporosis	0.000102	0.00159	CcSEcCtD
Bumetanide—Diarrhoea—Zoledronate—osteoporosis	0.000102	0.00159	CcSEcCtD
Bumetanide—Nausea—Risedronate—osteoporosis	0.000102	0.00159	CcSEcCtD
Bumetanide—Pruritus—Conjugated Estrogens—osteoporosis	0.000101	0.00158	CcSEcCtD
Bumetanide—Fatigue—Estradiol—osteoporosis	9.9e-05	0.00155	CcSEcCtD
Bumetanide—Dizziness—Zoledronate—osteoporosis	9.85e-05	0.00154	CcSEcCtD
Bumetanide—Diarrhoea—Conjugated Estrogens—osteoporosis	9.82e-05	0.00153	CcSEcCtD
Bumetanide—Nausea—Pamidronate—osteoporosis	9.69e-05	0.00151	CcSEcCtD
Bumetanide—Dizziness—Conjugated Estrogens—osteoporosis	9.49e-05	0.00148	CcSEcCtD
Bumetanide—Vomiting—Zoledronate—osteoporosis	9.47e-05	0.00148	CcSEcCtD
Bumetanide—Rash—Zoledronate—osteoporosis	9.39e-05	0.00147	CcSEcCtD
Bumetanide—Gastrointestinal pain—Estradiol—osteoporosis	9.39e-05	0.00147	CcSEcCtD
Bumetanide—Dermatitis—Zoledronate—osteoporosis	9.39e-05	0.00146	CcSEcCtD
Bumetanide—Headache—Zoledronate—osteoporosis	9.33e-05	0.00146	CcSEcCtD
Bumetanide—Vomiting—Conjugated Estrogens—osteoporosis	9.12e-05	0.00142	CcSEcCtD
Bumetanide—Urticaria—Estradiol—osteoporosis	9.12e-05	0.00142	CcSEcCtD
Bumetanide—Abdominal pain—Estradiol—osteoporosis	9.08e-05	0.00142	CcSEcCtD
Bumetanide—Rash—Conjugated Estrogens—osteoporosis	9.05e-05	0.00141	CcSEcCtD
Bumetanide—Dermatitis—Conjugated Estrogens—osteoporosis	9.04e-05	0.00141	CcSEcCtD
Bumetanide—Headache—Conjugated Estrogens—osteoporosis	8.99e-05	0.0014	CcSEcCtD
Bumetanide—Nausea—Zoledronate—osteoporosis	8.85e-05	0.00138	CcSEcCtD
Bumetanide—Nausea—Conjugated Estrogens—osteoporosis	8.52e-05	0.00133	CcSEcCtD
Bumetanide—Asthenia—Estradiol—osteoporosis	8.24e-05	0.00129	CcSEcCtD
Bumetanide—Pruritus—Estradiol—osteoporosis	8.12e-05	0.00127	CcSEcCtD
Bumetanide—Diarrhoea—Estradiol—osteoporosis	7.86e-05	0.00123	CcSEcCtD
Bumetanide—Dizziness—Estradiol—osteoporosis	7.59e-05	0.00119	CcSEcCtD
Bumetanide—Vomiting—Estradiol—osteoporosis	7.3e-05	0.00114	CcSEcCtD
Bumetanide—Rash—Estradiol—osteoporosis	7.24e-05	0.00113	CcSEcCtD
Bumetanide—Dermatitis—Estradiol—osteoporosis	7.23e-05	0.00113	CcSEcCtD
Bumetanide—Headache—Estradiol—osteoporosis	7.19e-05	0.00112	CcSEcCtD
Bumetanide—Nausea—Estradiol—osteoporosis	6.82e-05	0.00106	CcSEcCtD
Bumetanide—CA7—Metabolism—CYP27A1—osteoporosis	4.2e-05	0.00107	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TPI1—osteoporosis	4.18e-05	0.00106	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—OXCT1—osteoporosis	4.18e-05	0.00106	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CA2—osteoporosis	4.18e-05	0.00106	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPD2—osteoporosis	4.14e-05	0.00105	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PGLS—osteoporosis	4.14e-05	0.00105	CbGpPWpGaD
Bumetanide—CA12—Metabolism—IDH2—osteoporosis	4.14e-05	0.00105	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	4.13e-05	0.00105	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ACP5—osteoporosis	4.09e-05	0.00104	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ACP5—osteoporosis	4.09e-05	0.00104	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MGLL—osteoporosis	4.07e-05	0.00103	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TPI1—osteoporosis	4.07e-05	0.00103	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CA2—osteoporosis	3.98e-05	0.00101	CbGpPWpGaD
Bumetanide—CA4—Metabolism—OXCT1—osteoporosis	3.98e-05	0.00101	CbGpPWpGaD
Bumetanide—CA14—Metabolism—P4HB—osteoporosis	3.93e-05	0.000996	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.91e-05	0.000992	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP27A1—osteoporosis	3.89e-05	0.000987	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MGLL—osteoporosis	3.88e-05	0.000985	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GAPDH—osteoporosis	3.85e-05	0.000977	CbGpPWpGaD
Bumetanide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	3.85e-05	0.000976	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.84e-05	0.000973	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—P4HB—osteoporosis	3.83e-05	0.00097	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	3.82e-05	0.000967	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TPI1—osteoporosis	3.8e-05	0.000963	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TPI1—osteoporosis	3.8e-05	0.000963	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ATIC—osteoporosis	3.79e-05	0.00096	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ACP5—osteoporosis	3.79e-05	0.00096	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PNP—osteoporosis	3.79e-05	0.00096	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.78e-05	0.000958	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GAPDH—osteoporosis	3.76e-05	0.000952	CbGpPWpGaD
Bumetanide—CA14—Metabolism—RAP1A—osteoporosis	3.75e-05	0.000952	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.68e-05	0.000932	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—RAP1A—osteoporosis	3.66e-05	0.000928	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.63e-05	0.000921	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.6e-05	0.000912	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.58e-05	0.000909	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—P4HB—osteoporosis	3.57e-05	0.000906	CbGpPWpGaD
Bumetanide—CA7—Metabolism—P4HB—osteoporosis	3.57e-05	0.000906	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TPI1—osteoporosis	3.52e-05	0.000893	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GAPDH—osteoporosis	3.51e-05	0.000889	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GAPDH—osteoporosis	3.51e-05	0.000889	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—IDH2—osteoporosis	3.46e-05	0.000878	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—RAP1A—osteoporosis	3.42e-05	0.000866	CbGpPWpGaD
Bumetanide—CA7—Metabolism—RAP1A—osteoporosis	3.42e-05	0.000866	CbGpPWpGaD
Bumetanide—CA12—Metabolism—P4HB—osteoporosis	3.31e-05	0.000839	CbGpPWpGaD
Bumetanide—CA4—Metabolism—IDH2—osteoporosis	3.3e-05	0.000837	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP27A1—osteoporosis	3.25e-05	0.000825	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GAPDH—osteoporosis	3.25e-05	0.000824	CbGpPWpGaD
Bumetanide—CA9—Metabolism—OXCT1—osteoporosis	3.22e-05	0.000816	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CA2—osteoporosis	3.22e-05	0.000816	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ACP5—osteoporosis	3.17e-05	0.000803	CbGpPWpGaD
Bumetanide—CA12—Metabolism—RAP1A—osteoporosis	3.16e-05	0.000802	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MGLL—osteoporosis	3.14e-05	0.000796	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.13e-05	0.000792	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP27A1—osteoporosis	3.1e-05	0.000787	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.06e-05	0.000775	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ENO1—osteoporosis	3.03e-05	0.000769	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ACP5—osteoporosis	3.02e-05	0.000766	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	3.01e-05	0.000763	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PSMA2—osteoporosis	2.99e-05	0.000758	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PSMA5—osteoporosis	2.99e-05	0.000758	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.96e-05	0.000751	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ENO1—osteoporosis	2.96e-05	0.00075	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TPI1—osteoporosis	2.94e-05	0.000746	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PSMA2—osteoporosis	2.91e-05	0.000739	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PSMA5—osteoporosis	2.91e-05	0.000739	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—LEP—osteoporosis	2.81e-05	0.000712	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TPI1—osteoporosis	2.81e-05	0.000712	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PKM—osteoporosis	2.79e-05	0.000707	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—FDPS—osteoporosis	2.79e-05	0.000707	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.79e-05	0.000707	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—P4HB—osteoporosis	2.77e-05	0.000702	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ENO1—osteoporosis	2.76e-05	0.0007	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ENO1—osteoporosis	2.76e-05	0.0007	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.76e-05	0.0007	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PSMA2—osteoporosis	2.72e-05	0.00069	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PSMA2—osteoporosis	2.72e-05	0.00069	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PSMA5—osteoporosis	2.72e-05	0.00069	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PSMA5—osteoporosis	2.72e-05	0.00069	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GAPDH—osteoporosis	2.72e-05	0.000689	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.72e-05	0.000689	CbGpPWpGaD
Bumetanide—CA9—Metabolism—IDH2—osteoporosis	2.67e-05	0.000676	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—RAP1A—osteoporosis	2.65e-05	0.000671	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPD2—osteoporosis	2.64e-05	0.00067	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PGLS—osteoporosis	2.64e-05	0.00067	CbGpPWpGaD
Bumetanide—CA4—Metabolism—P4HB—osteoporosis	2.64e-05	0.000669	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GAPDH—osteoporosis	2.59e-05	0.000657	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	2.58e-05	0.000655	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ENO1—osteoporosis	2.56e-05	0.000649	CbGpPWpGaD
Bumetanide—CA4—Metabolism—RAP1A—osteoporosis	2.52e-05	0.00064	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PSMA2—osteoporosis	2.52e-05	0.000639	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PSMA5—osteoporosis	2.52e-05	0.000639	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP27A1—osteoporosis	2.51e-05	0.000636	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ACP5—osteoporosis	2.44e-05	0.000619	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP19A1—osteoporosis	2.43e-05	0.000615	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PNP—osteoporosis	2.42e-05	0.000613	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ATIC—osteoporosis	2.42e-05	0.000613	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP19A1—osteoporosis	2.36e-05	0.000599	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.31e-05	0.000585	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TPI1—osteoporosis	2.27e-05	0.000575	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	2.26e-05	0.000574	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP19A1—osteoporosis	2.21e-05	0.00056	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP19A1—osteoporosis	2.21e-05	0.00056	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.17e-05	0.00055	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.17e-05	0.000549	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ENO1—osteoporosis	2.14e-05	0.000542	CbGpPWpGaD
Bumetanide—CA9—Metabolism—P4HB—osteoporosis	2.13e-05	0.000541	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PSMA2—osteoporosis	2.11e-05	0.000534	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PSMA5—osteoporosis	2.11e-05	0.000534	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GAPDH—osteoporosis	2.09e-05	0.000531	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CA2—osteoporosis	2.06e-05	0.000521	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—OXCT1—osteoporosis	2.06e-05	0.000521	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP19A1—osteoporosis	2.04e-05	0.000518	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ENO1—osteoporosis	2.04e-05	0.000517	CbGpPWpGaD
Bumetanide—CA9—Metabolism—RAP1A—osteoporosis	2.04e-05	0.000517	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PKM—osteoporosis	2.01e-05	0.00051	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SOST—osteoporosis	2.01e-05	0.00051	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PSMA5—osteoporosis	2.01e-05	0.00051	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PSMA2—osteoporosis	2.01e-05	0.00051	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MGLL—osteoporosis	2e-05	0.000508	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ADCY5—osteoporosis	1.98e-05	0.000503	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GPX1—osteoporosis	1.98e-05	0.000501	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.97e-05	0.000498	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ADCY5—osteoporosis	1.93e-05	0.00049	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GPX1—osteoporosis	1.93e-05	0.000488	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ANTXR2—osteoporosis	1.91e-05	0.000483	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PGLS—osteoporosis	1.91e-05	0.000483	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.89e-05	0.000479	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.85e-05	0.000468	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.83e-05	0.000464	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.82e-05	0.000463	CbGpPWpGaD
Bumetanide—CA14—Metabolism—MTHFR—osteoporosis	1.82e-05	0.000462	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ADCY5—osteoporosis	1.8e-05	0.000457	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ADCY5—osteoporosis	1.8e-05	0.000457	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GPX1—osteoporosis	1.8e-05	0.000456	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GPX1—osteoporosis	1.8e-05	0.000456	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.79e-05	0.000454	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—MTHFR—osteoporosis	1.78e-05	0.00045	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP19A1—osteoporosis	1.71e-05	0.000433	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—IDH2—osteoporosis	1.7e-05	0.000432	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FDPS—osteoporosis	1.68e-05	0.000427	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PKM—osteoporosis	1.68e-05	0.000427	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ADCY5—osteoporosis	1.67e-05	0.000424	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GPX1—osteoporosis	1.67e-05	0.000422	CbGpPWpGaD
Bumetanide—CA7—Metabolism—MTHFR—osteoporosis	1.66e-05	0.000421	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—MTHFR—osteoporosis	1.66e-05	0.000421	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.65e-05	0.000419	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ENO1—osteoporosis	1.65e-05	0.000418	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.64e-05	0.000417	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP19A1—osteoporosis	1.63e-05	0.000413	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000412	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000412	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GSN—osteoporosis	1.62e-05	0.000411	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP27A1—osteoporosis	1.6e-05	0.000406	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PGLS—osteoporosis	1.6e-05	0.000405	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPD2—osteoporosis	1.6e-05	0.000405	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.58e-05	0.0004	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ACP5—osteoporosis	1.56e-05	0.000395	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.54e-05	0.00039	CbGpPWpGaD
Bumetanide—CA12—Metabolism—MTHFR—osteoporosis	1.54e-05	0.00039	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.47e-05	0.000372	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PNP—osteoporosis	1.46e-05	0.00037	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ATIC—osteoporosis	1.46e-05	0.00037	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—osteoporosis	1.46e-05	0.00037	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TPI1—osteoporosis	1.45e-05	0.000367	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—osteoporosis	1.43e-05	0.000362	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—osteoporosis	1.42e-05	0.00036	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LRP5—osteoporosis	1.41e-05	0.000357	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ADCY5—osteoporosis	1.4e-05	0.000354	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—osteoporosis	1.39e-05	0.000354	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPX1—osteoporosis	1.39e-05	0.000353	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	1.39e-05	0.000353	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.38e-05	0.00035	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—P4HB—osteoporosis	1.36e-05	0.000345	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LRP6—osteoporosis	1.35e-05	0.000342	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GAPDH—osteoporosis	1.34e-05	0.000339	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ADCY5—osteoporosis	1.33e-05	0.000338	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPX1—osteoporosis	1.33e-05	0.000337	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—osteoporosis	1.33e-05	0.000336	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—osteoporosis	1.33e-05	0.000336	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	1.33e-05	0.000336	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP19A1—osteoporosis	1.32e-05	0.000334	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RAP1A—osteoporosis	1.3e-05	0.00033	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—osteoporosis	1.3e-05	0.000329	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LTF—osteoporosis	1.3e-05	0.000328	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL24—osteoporosis	1.3e-05	0.000328	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MTHFR—osteoporosis	1.28e-05	0.000326	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—OXCT1—osteoporosis	1.24e-05	0.000315	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA2—osteoporosis	1.24e-05	0.000315	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—osteoporosis	1.23e-05	0.000312	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MTHFR—osteoporosis	1.23e-05	0.000311	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MGLL—osteoporosis	1.21e-05	0.000307	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.14e-05	0.000289	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.13e-05	0.000288	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ACP5—osteoporosis	1.12e-05	0.000285	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000273	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX1—osteoporosis	1.07e-05	0.000272	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO1—osteoporosis	1.05e-05	0.000267	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—osteoporosis	1.05e-05	0.000266	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TPI1—osteoporosis	1.04e-05	0.000265	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000263	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000263	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—IDH2—osteoporosis	1.03e-05	0.000261	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—osteoporosis	1.03e-05	0.00026	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—osteoporosis	9.9e-06	0.000251	CbGpPWpGaD
Bumetanide—PTGS2—Disease—P4HB—osteoporosis	9.82e-06	0.000249	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—osteoporosis	9.8e-06	0.000248	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP27A1—osteoporosis	9.67e-06	0.000245	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GAPDH—osteoporosis	9.64e-06	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.49e-06	0.000241	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.47e-06	0.00024	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ACP5—osteoporosis	9.41e-06	0.000238	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.29e-06	0.000235	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NFATC1—osteoporosis	9.16e-06	0.000232	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DKK1—osteoporosis	9.08e-06	0.00023	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.84e-06	0.000224	CbGpPWpGaD
Bumetanide—PTGS2—Disease—WNT1—osteoporosis	8.75e-06	0.000222	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TPI1—osteoporosis	8.74e-06	0.000222	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGA—osteoporosis	8.51e-06	0.000216	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP19A1—osteoporosis	8.41e-06	0.000213	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—P4HB—osteoporosis	8.22e-06	0.000208	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GAPDH—osteoporosis	8.07e-06	0.000205	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—osteoporosis	7.92e-06	0.000201	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RAP1A—osteoporosis	7.86e-06	0.000199	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO1—osteoporosis	7.59e-06	0.000192	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSMA2—osteoporosis	7.48e-06	0.00019	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSMA5—osteoporosis	7.48e-06	0.00019	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CALCA—osteoporosis	6.97e-06	0.000177	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADCY5—osteoporosis	6.87e-06	0.000174	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.85e-06	0.000174	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX1—osteoporosis	6.85e-06	0.000174	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO1—osteoporosis	6.35e-06	0.000161	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KL—osteoporosis	6.33e-06	0.00016	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—osteoporosis	6.32e-06	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSMA2—osteoporosis	6.26e-06	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSMA5—osteoporosis	6.26e-06	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP19A1—osteoporosis	5.08e-06	0.000129	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—osteoporosis	5.05e-06	0.000128	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ADCY5—osteoporosis	4.96e-06	0.000126	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—osteoporosis	4.56e-06	0.000116	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS2—osteoporosis	4.34e-06	0.00011	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADCY5—osteoporosis	4.15e-06	0.000105	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX1—osteoporosis	4.14e-06	0.000105	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—osteoporosis	3.82e-06	9.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS1—osteoporosis	3.79e-06	9.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6R—osteoporosis	3.56e-06	9.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—osteoporosis	3.05e-06	7.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—osteoporosis	2.11e-06	5.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—osteoporosis	2.1e-06	5.33e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—osteoporosis	1.58e-06	4.02e-05	CbGpPWpGaD
